KPIs & Operating Metrics(New)
Balance Sheet
Cash Flow Statement
Daily Values
Growth Metrics
Income Statement
Consolidated Net IncomeCost of RevenueDepreciation & Amortization - TotalEBITEBITDAEBTEPS (Basic)EPS (Weighted Average and Diluted)Gross ProfitIncome from Continuing OperationsIncome towards Parent CompanyInterest & Investment IncomeNet Income towards Common StockholdersNon Operating IncomeOperating ExpensesOperating IncomeOther Non Operating IncomeOther Operating ExpensesProfit After TaxResearch & DevelopmentRevenueSelling, General & AdministrativeShares OutstandingShares Outstanding (Diluted Average)Shares Outstanding (Weighted Average)Tax ProvisionsTax RateTax Rate
Others
Ratios

AbCellera Biologics (ABCL) Tax Rate (2021 - 2026)

AbCellera Biologics filings provide 6 years of Tax Rate readings, the most recent being 12.86% for Q1 2026.

  • Quarterly Tax Rate fell 103.0% to 12.86% in Q1 2026 from the year-ago period, while the trailing twelve-month figure was 17.34% through Mar 2026, down 297.0% year-over-year, with the annual reading at 17.56% for FY2025, 117.0% down from the prior year.
  • Tax Rate hit 12.86% in Q1 2026 for AbCellera Biologics, down from 54.13% in the prior quarter.
  • Across five years, Tax Rate topped out at 54.13% in Q4 2025 and bottomed at 1.47% in Q2 2022.
  • Average Tax Rate over 5 years is 18.74%, with a median of 16.94% recorded in 2025.
  • Peak annual rise in Tax Rate hit 2847bps in 2022, while the deepest fall reached -2440bps in 2022.
  • AbCellera Biologics' Tax Rate stood at 4.84% in 2022, then plummeted by -38bps to 2.99% in 2023, then surged by 802bps to 26.95% in 2024, then skyrocketed by 101bps to 54.13% in 2025, then plummeted by -76bps to 12.86% in 2026.
  • Per Business Quant, the three most recent readings for ABCL's Tax Rate are 12.86% (Q1 2026), 54.13% (Q4 2025), and 16.94% (Q3 2025).